Karim H Saba
6PUBLICATIONS
22CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Sep 25, 2024
CDK4 is co-amplified with either TP53 promoter gene fusions or MDM2 through distinct mechanisms in osteosarcoma.Karim H Saba, Valeria Difilippo, Emelie Styring
|Nov 27, 2023
Disruption of the TP53 locus in osteosarcoma leads to TP53 promoter gene fusions and restoration of parts of the TP53 signalling pathway.Karim H Saba, Valeria Difilippo, Michal Kovac
|Sep 20, 2022
Inactivation of RB1, CDKN2A, and TP53 have distinct effects on genomic stability at side-by-side comparison in karyotypically normal cells.Natalie Andersson, Karim H Saba, Linda Magnusson
|Jun 17, 2020
Loss of NF2 defines a genetic subgroup of non-FOS-rearranged osteoblastoma.Karim H Saba, Louise Cornmark, Jakob Hofvander
|Feb 07, 2020
Clonal competition within complex evolutionary hierarchies shapes AML over time.Carl Sandén, Henrik Lilljebjörn, Christina Orsmark Pietras
|May 09, 2019
Genetic profiling of a chondroblastoma-like osteosarcoma/malignant phosphaturic mesenchymal tumor of bone reveals a homozygous deletion of CDKN2A, intragenic deletion of DMD, and a targetable FN1-FGFR1 gene fusion.Karim H Saba, Louise Cornmark, Marianne Rissler
Pageof 1
Frequent Collaborators
5 joint publications
Karolin H Nord
2 joint publications
Felix Haglund de Flon
2 joint publications
David Gisselsson
1 joint publications
Carl Sandén
1 joint publications
Henrik Lilljebjörn
1 joint publications
Niklas Landberg
1 joint publications
Sofia von Palffy
1 joint publications
Pablo Peña-Martinez
1 joint publications
Vladimir Lazarevic
1 joint publications
Jakob Hofvander
